FDA Human Foods Program
FDA Releases Additional Information ahead of Listeria Prevention Public Meeting
View on the FDA Website
August 3, 2026
The FDA is sharing additional information ahead of the public meeting on Listeria monocytogenes prevention planned for August 18-19, 2026.
During the upcoming public meeting the FDA hopes to foster discussions around a number of topics including:
- Advances in the Understanding and Control of L. monocytogenes
- Best Practices in L. monocytogenes prevention
-
L. monocytogenes Dose-Response Modeling: Applications and Advancements
- Using Food Safety Management Systems for Controlling L. monocytogenes in Retail Environments
- Preventing Listeriosis in an Era of Changing Demographics and Dietary Patterns
Today, the agency released an agenda for the public meeting which outlines several sessions focused on these topics and a document outlining key questions the agency hopes will inform discussions both during and beyond the public meeting. Additionally, FDA has opened a docket where interested stakeholders can submit comments related to these topics, the key questions, or other helpful information related to Listeria prevention. The docket will be open for 90 days.
As a reminder, registration is currently open for the public meeting. More information can be found on the meeting webpage.
For More Information
|
